Eisai to focus on pharma, divesting its food business to Mitsubishi

27 November 2015
mergers-acquisitions-big

Japanese pharma major Eisai (TYO: 4523) has agreed to transfer all shares in its wholly-owned subsidiary Eisai Food & Chemical Chitaka Suzuki to Mitsubishi-Kagaku Foods, a subsidiary of Mitsubishi Chemical.

Following the transfer, of which no financial terms were revealed, Eisai will further concentrate management resources in its pharmaceutical business, and will strive to increase corporate value by speeding up innovation.

Established in April 2004, Eisai Food & Chemical is engaged in the development, marketing and export of pharmaceutical and cosmetic raw materials, food ingredients and food additives, supplements and nutrition. The food unit generated sales of 9,005 million yen (around $73 million) in the fiscal year ended March 2015.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical